| Literature DB >> 2910207 |
M Okano1, M Nomura, S Hata, N Okada, K Sato, Y Kitano, M Tashiro, Y Yoshimoto, R Hama, T Aoki.
Abstract
Six patients who developed urticaria, dyspnea, and anaphylactic shock due to topical application of chlorhexidine gluconate solution are described. Chlorhexidine gluconate was confirmed as the causative agent of type I hypersensitivity by intradermal, scratch, and epicutaneous tests. To prevent life-threatening adverse reactions, it seems important to use chlorhexidine gluconate on wound surfaces at a concentration of 0.05%, as recommended by the manufacturer; chlorhexidine gluconate may not be suitable for application to mucous membranes.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2910207
Source DB: PubMed Journal: Arch Dermatol ISSN: 0003-987X